back

 



Medicare Nominee Avoids Senators' Queries

By Mark Sherman, the Associated Press

March 8, 2004  

WASHINGTON - Mark McClellan, President Bush's choice to run Medicare, said Monday he won't answer senators' questions about his opposition to importing prescription drugs from Canada before he takes over the government health program.  

Republican leaders in the Senate want to vote to confirm McClellan by the end of the week, as the Centers for Medicare and Medicaid Services tries to put in place the Medicare overhaul that Bush signed last year.  

However, McClellan's rejection of the request from Republican John McCain of Arizona and Democrats Byron Dorgan of North Dakota and Debbie Stabenow of Michigan sets up the prospect that they will use Senate procedures to drag out the confirmation.  

McClellan, at a hearing on his nomination at the Senate Finance Committee, said he would answer the senators' questions "as soon as this confirmation process is concluded."  

The senators want him to appear before the Senate Commerce, Science and Transportation Committee, which McCain leads and where he could expect more aggressive questioning than he received Monday.  

Told of McClellan's comments, Dorgan spokesman Barry Piatt said: "That's an absurd response that borders on the arrogant. He doesn't get to choose which senators can ask him questions." McCain spokesman Marshall Wittman said the senator is still awaiting a formal response from McClellan.  

As commissioner of the Food and Drug Administration, McClellan has been the Bush administration's leading voice in opposition to allowing prescription drugs into this country from Canada , where they often are cheaper. McClellan, other government officials and pharmaceutical companies have raised questions about safety.  

Health and Human Services Secretary Tommy Thompson recently named McClellan to lead a panel to study whether and at what cost drugs could be safely imported. Critics argued the study would be one-sided, although Thompson pledged the panel would be balanced.  

Drug importation has widespread support in Congress and across the country as a result of several years of double-digit increases in prescription drug prices. Nearly two-thirds of those surveyed in an Associated Press poll released last month said the government should make it easier to buy cheaper drugs from Canada or other countries.  

AARP, the 35-million-member seniors organization, released a letter Monday that chief executive William Novelli sent to 16 drug manufacturers, urging them to support drug importation legislation "with strict procedures to ensure safety." Novelli also called on the companies to limit price increases to the rate of inflation.  

McClellan's nomination is expected to clear the Senate easily once it comes to a vote. In 2002, the Senate confirmed McClellan to lead the FDA with no opposition.  

There is no dispute about qualifications. McClellan is a physician and economist who was a member of Bush's Council of Economic Advisers before taking over at the FDA. He also served in the Clinton administration. 

Copyright © 2004 Global Action on Aging
Terms of Use  |  Privacy Policy  |  Contact Us